Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company"), a clinical-stage biotechnology company pioneering mRNA cell therapies for the treatment ...

The presence of antiarrestin autoantibodies among patients with SLE is associated with an increased risk of developing HCQ-related retinal toxicity.

“Living alone, I rely on my parents and friends to help with daily tasks during flares,” she shares. “This experience has ...

Chronic inflammatory diseases are becoming a leading pathology and the main cause of death in Western civilization. Persistent inflammation is thought to be ...

Controlling cardiovascular risk factors and maintaining long-term disease remission mitigated the increased risk for ...

Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...

The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) ...

Columnist Candace Semien praises the community's ability to survive and thrive without guilt while living with lupus.

Barclays PLC purchased a new position in shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the ...

A history of infertility without fertility treatment was associated with a higher future risk of SARD, independent of co-existing adverse pregnancy outcomes.

Patients with SLE have a higher prevalence of primary headaches vs those with RA or pSS, but similar percentages were found ...

The increased risks for arterial thrombotic events (ATE), venous thromboembolism (VTE), and all-cause mortality known to be found among patients with systemic lupus erythematosus (SLE) were validated ...